Canaccord Genuity reiterates a 'Buy' on RTI Biologics (NASDAQ: RTIX) price target of $5.50 (from $6.50).

Analyst, William J ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE